News

FIGS raises its 2026 outlook after strong Q2 growth, with higher revenue and margin targets despite second-half execution risks.

ONON's DTC momentum and Asia-Pacific growth drive stronger margins. The company raises its 2026 gross margin outlook.

FIGS' accelerating growth and improving margins support its momentum, but a rich valuation raises the bar for further gains.

FIGS delivers 28.8% Q2 revenue growth and higher margins, but its premium valuation raises the bar for continued momentum.

Does Figs (FIGS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Healthcare apparel company Figs (NYSE:FIGS) announced better-than-expected revenue in Q2 CY2026, with sales up 28.8% year on year to $196.6 million. Its non-GAAP profit of $0.11 per share was 66.9% above analysts’ consensus estimates.

Here is how Figs (FIGS) and Dick's Sporting Goods (DKS) have performed compared to their sector so far this year.

Shares of healthcare apparel company Figs (NYSE:FIGS) jumped 28.5% in the afternoon session after the healthcare apparel company reported second-quarter 2026 results that beat Wall Street on both revenue and adjusted earnings. FIGS is converting more customers into bigger baskets: active customers rose 13% to 3.1 million, average order value climbed to $127, and adjusted EPS of $0.11 cleared the $0.07 consensus as margins expanded sharply. Management tied the $196.6 million revenue print (+28.8%

Figs stock exploded on Friday -- and is still cheap.

Why FIGS stock moved on fresh earnings news FIGS (FIGS) caught investors’ attention after second quarter 2026 results and a higher full year revenue outlook, combined with an expanded share repurchase plan. Together, these developments framed a clear new information reset for the stock. See our latest analysis for FIGS. FIGS has seen sharp momentum build around this earnings release, with a 1-day share price return of 26.87% and a 30-day share price return of 42.03%, while its 1-year total...

FIGS (NYSE:FIGS) reported second-quarter fiscal 2026 revenue growth of 29% as demand increased across scrub wear, non-scrub apparel, international markets, institutional sales and retail community hubs. The healthcare apparel company also raised its full-year revenue and profitability outlook, despi

The leading apparel brand for healthcare professionals offers investors a lucrative combination of growth and profitability.

PZZA's Q2 earnings and revenues beat estimates, but shares sink 17.2% as weaker comps, reduced 2026 guidance and a dividend suspension weigh.

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3%, and the actively tra

Figs (NYSE:FIGS) shares surged 27. 7% in premarket trading after the healthcare apparel company reported second-quarter 2026 results that comfortably exceeded Wall Street expectations.

Moby summary of FIGS, Inc.'s Q2 2026 earnings call

Figs (FIGS) delivered earnings and revenue surprises of +57.14% and +5.66%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Although the revenue and EPS for Figs (FIGS) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Healthcare apparel company Figs (NYSE:FIGS) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 28.8% year on year to $196.6 million. Its GAAP profit of $0.15 per share was significantly above analysts’ consensus estimates.

SHAK's Q2 earnings beat estimates and revenues rose 17.2% YoY, but beef inflation and higher costs pressured margins.

BROS tops Q2 estimates with strong comps and expansion, lifts 2026 outlook as new shops and traffic growth fuel momentum.

FIGS heads into Q2 earnings with product innovation, global expansion and demand momentum in focus, while tariffs and freight costs may have pressured margins.

Capri Holdings (CPRI) delivered earnings and revenue surprises of +67.50% and +2.51%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

MCD's Q2 earnings beat estimates as stronger franchised margins offset a revenue miss, while comparable sales rise across all three segments.

Since January 2026, Figs has been in a holding pattern, posting a small loss of 0.5% while floating around $10.75. The stock also fell short of the S&P 500’s 7.1% gain during that period.

CMG's second-quarter results reflect benefits from positive comparable sales, restaurant expansion and stronger digital engagement.

YUM tops earnings estimates as Taco Bell's strong sales and global expansion help offset softer Pizza Hut performance.

BLDR stock is down after second-quarter earnings and sales miss estimates, with weaker housing demand and a lower 2026 outlook adding to investor concerns.

SBUX's shares jump after fiscal third-quarter adjusted earnings beat estimates, comparable sales rise and management lifts fiscal 2026 guidance.

DPZ's fiscal second-quarter results reflect benefits from order growth across both delivery and carryout channels.